Jacobs Levy Equity Management, Inc Synlogic, Inc. Transaction History

Jacobs Levy Equity Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $30,925 - $48,381	-18,973 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $174,830 - $231,054	-77,018 Reduced 80.23%	18,973 $46,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $47,944 - $80,232	-19,569 Reduced 16.93%	95,991 $293,000
Q2 2021 Aug 16, 2021	SELL	$3.0 - $4.39 $501,168 - $733,375	-167,056 Reduced 59.11%	115,560 $450,000
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $74,529 - $171,078	33,877 Added 13.62%	282,616 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$1.85 - $2.54 $460,167 - $631,797	248,739 New	248,739 $537,000
Q1 2020 May 15, 2020	SELL	$1.39 - $3.19 $141,055 - $323,718	-101,479 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.96 - $2.81 $198,898 - $285,155	101,479 New	101,479 $262,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.